Multicenter review suggests tunneled pleural catheter use in antineoplastic therapy-related immunosuppression does not increase infection rate

C. Wilshire (Seattle, United States of America), C. Gilbert (Seattle, United States of America), J. Akulian (Chapel Hill, United States of America), R. Asciak (Oxford, United Kingdom), B. Bevill (Charleston, United States of America), K. Davidson (Durham, United States of America), A. Delgado (Chapel Hill, United States of America), H. Lee (Baltimore, United States of America), J. Lewis (Charleston, United States of America), F. Maldonado (Nashville, United States of America), N. Pastis (Charleston, United States of America), N. Rahman (Oxford, United Kingdom), C. Reddy (Salt Lake City, United States of America), L. Roller (Nashville, United States of America), H. Steer (Gloucester, United Kingdom), M. Wahidi (Durham, United States of America), H. West (Seattle, United States of America), A. Wright (Chapel Hill, United States of America), L. Yarmus (Baltimore, United States of America), J. Gorden (Seattle, United States of America)

Source: International Congress 2018 – Pleural interventions
Session: Pleural interventions
Session type: Thematic Poster
Number: 886
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Wilshire (Seattle, United States of America), C. Gilbert (Seattle, United States of America), J. Akulian (Chapel Hill, United States of America), R. Asciak (Oxford, United Kingdom), B. Bevill (Charleston, United States of America), K. Davidson (Durham, United States of America), A. Delgado (Chapel Hill, United States of America), H. Lee (Baltimore, United States of America), J. Lewis (Charleston, United States of America), F. Maldonado (Nashville, United States of America), N. Pastis (Charleston, United States of America), N. Rahman (Oxford, United Kingdom), C. Reddy (Salt Lake City, United States of America), L. Roller (Nashville, United States of America), H. Steer (Gloucester, United Kingdom), M. Wahidi (Durham, United States of America), H. West (Seattle, United States of America), A. Wright (Chapel Hill, United States of America), L. Yarmus (Baltimore, United States of America), J. Gorden (Seattle, United States of America). Multicenter review suggests tunneled pleural catheter use in antineoplastic therapy-related immunosuppression does not increase infection rate. 886

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A multicentre study evaluating bleeding risk with intrapleural enzyme therapy in pleural infection (RETROLYSIS)
Source: Virtual Congress 2021 – Novelties in interventional pulmonology
Year: 2021



Variable adoption of intrapleural fibrinolytic therapy for pleural space infections
Source: International Congress 2018 – Pleural interventions
Year: 2018

Effectiveness and safety of tunneled pleural catheter placement in patients with malignant pleural effusions
Source: International Congress 2019 – Interventional pulmonology: current pleural practice
Year: 2019


The second therapeutic intervention in malignant effusion trial (TIME2): A randomised controlled trial to assess the efficacy and safety of patient controlled malignant pleural effusion drainage by indwelling pleural catheter compared to chest drain and talc slurry pleurodesis
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012

The long-term follow-up study of 8 french catheter effects in the treatment of spontaneous pneumothorax
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001

Impact of indwelling pleural catheter on quality of life in management of malignant pleural effusion in patients with advanced malignancies
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012



The use of the PleurX catheter in the management of recurrent non-malignant pleural effusions
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010


High-flow nasal cannula therapy has the effectiveness for acute respiratory failure including hypercapnic status:a single-centered retrospective study.
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018


The use of totally implantable central venous access ports for the treatment of multidrug-resistant tuberculosis (MDR-TB) at the programmatic level. Prospective cohort study
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Outpatient management of primary spontaneous pneumothorax using small-bore catheter: A prospective study
Source: Annual Congress 2011 - Pleural diseases and pneumothorax
Year: 2011


Bleeding risk of pleural procedures in patients taking antiplatelet therapy: A multicentric prospective study
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015

LATE-BREAKING ABSTRACT: Spontaneous pleurodesis rates in chemotherapy and non-chemotherapy patients undergoing indwelling pleural catheter insertion for malignant pleural effusion
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016


Prospective observational study on short-term and long-term effects of elective performed intravascular treatment using gelatin sponge for recurrent hemoptysis or chronic sustained hemosputum
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019


An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection
Source: ERJ Open Res, 8 (1) 00590-2021; 10.1183/23120541.00590-2021
Year: 2022



Efficacy and complications of small-bore catheters in the management of malignant pleural effusions
Source: Eur Respir J 2007; 30: Suppl. 51, 103s
Year: 2007

Outcomes of an elective day case tunnelled indwelling pleural catheter service
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Bleeding complications after pleural procedures in patients on antiplatelet therapy: A French survey
Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases
Year: 2013

Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital.
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Pleurodesis after intrapleural catheter insertion is an independent factor for overall survival in patients with malignant pleural effusions
Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Year: 2009